Cita APA

Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., . . . Haining, W. N. (2017). In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature.

Citación estilo Chicago

Manguso, Robert T., et al. "In Vivo CRISPR Screening Identifies Ptpn2 As a Cancer Immunotherapy Target." Nature 2017.

Cita MLA

Manguso, Robert T., et al. "In Vivo CRISPR Screening Identifies Ptpn2 As a Cancer Immunotherapy Target." Nature 2017.